Nature Reviews Endocrinology Impact Factor 2025 (JCR 2026): 39.1, Q1, Ranking & Metrics

Last Updated on July 16, 2026 by Dr. Bhagat

JOURNAL METRICS·Updated June 2026

Nature Reviews Endocrinology Impact Factor 2025: 39.1, Q1 Endocrinology & Metabolism Metrics

Nature Reviews Endocrinology Impact Factor 2025 stands at 39.1 (Q1, Endocrinology, Science Citation Index Expanded (SCIE)). Since 2005, this Springer Nature review journal has shaped how clinicians and researchers understand hormonal health and metabolic disease.

39.1
2025 Impact Factor
Q1
JCR Quartile
48.5
CiteScore
11.2
SJR Score
155
H-Index

JOURNAL PROFILENature Reviews Endocrinology at a Glance

Since its founding in 2005, Nature Reviews Endocrinology has served as the preeminent review journal for endocrinology and metabolism. Published by Springer Nature with ISSN 1759-5029, the journal delivers monthly reviews that bridge bench research and clinical practice. Its impact factor of 39.1 reflects both the clinical importance of endocrinology — diabetes alone affects over 500 million people worldwide — and the journal’s editorial excellence in commissioning reviews that genuinely move the field forward.

Endocrinology sits at the intersection of multiple medical specialties. Hormonal signaling influences cardiovascular function, bone metabolism, reproductive health, energy balance, immune regulation, and cancer progression. Nature Reviews Endocrinology’s editorial scope embraces this breadth, publishing reviews that range from the molecular biology of nuclear receptors to population-level epidemiology of metabolic disease. This wide remit helps explain the journal’s broad citation base and its ability to sustain an impact factor above 39.

Indicator Value Database / Source
Impact Factor 39.1 JCR 2025 (Clarivate)
JCR Quartile Q1 Top 25% in Endocrinology
CiteScore 48.5 Scopus 2025
SJR 11.2 Scimago 2025
H-Index 155 Google Scholar
ISSN 1759-5029 ISSN Portal
Publisher Springer Nature Since 2005
Subject Endocrinology Clarivate JCR
Frequency Monthly Monthly publication
Indexing Science Citation Index Expanded (SCIE) Clarivate SCIE

Key Takeaways

  • IF 2025: 39.1 — among the highest of any endocrinology journal
  • Q1 ranking: Q1 in Endocrinology per Clarivate JCR 2025
  • CiteScore 48.5: Scopus confirms broad, sustained citation performance
  • SJR 11.2: Citations from prestigious journals signal trusted authority
  • Established 2005: Over two decades of editorial excellence

CLINICAL IMPACTWhy 39.1 Matters in Endocrinology

The impact factor of 39.1 places Nature Reviews Endocrinology among the most influential publications in endocrine and metabolic medicine. In a clinical discipline where treatment guidelines evolve in response to new evidence, high-quality reviews play an outsized role in shaping practice. A review published in Nature Reviews Endocrinology on the management of type 2 diabetes, for example, is likely to be cited by guideline committees, pharmaceutical researchers, and practicing clinicians around the world.

This clinical relevance is amplified by the journal’s commitment to translational research. Nature Reviews Endocrinology actively seeks reviews that connect molecular mechanisms to clinical outcomes — explaining, for instance, how new insights into insulin signaling pathways are informing the development of next-generation glucose-lowering therapies. This translational emphasis makes the journal indispensable to both researchers and clinicians.

CROSS-DATABASE ANALYSISScopus and Google Scholar Perspectives

The CiteScore of 48.5 from Scopus uses a four-year citation window and provides a more stable, long-term view of citation performance than the two-year impact factor. That Nature Reviews Endocrinology’s CiteScore exceeds its IF indicates that articles continue to accumulate citations well beyond the initial publication period — a pattern consistent with the foundational role that reviews play in clinical education and practice.

The h-index of 155 means that Nature Reviews Endocrinology has published at least 155 papers that have each been cited 155 or more times. Given the journal’s focus on commissioned reviews, this metric reflects the consistent ability of its editorial team to identify topics and authors of lasting significance. The SJR of 11.2 further confirms that citations come from selective, high-prestige sources.

SCOPE OF COVERAGETopics in Nature Reviews Endocrinology

The journal covers the full spectrum of endocrinology and metabolism, including diabetes mellitus and glucose homeostasis, thyroid disorders, adrenal and pituitary disease, bone metabolism and osteoporosis, reproductive endocrinology, neuroendocrinology, obesity and energy balance, lipid metabolism, endocrine oncology, pediatric endocrinology, and hormone action and signaling mechanisms.

Recent years have seen increased coverage of integrative physiology, the endocrine effects of the microbiome, epigenetic regulation of metabolic disease, and the metabolic complications of cancer immunotherapy. The journal also publishes reviews on health policy and health economics relevant to endocrine care, reflecting its commitment to improving patient outcomes beyond the laboratory.

PUBLICATION GUIDANCEContributing to Nature Reviews Endocrinology

Nature Reviews Endocrinology primarily publishes commissioned review articles. The editorial team identifies timely topics and invites recognized experts to contribute. Authors interested in writing for the journal should contact the editorial office with a proposal that includes a clear outline of the topic, its clinical or scientific importance, and its potential to advance the field.

Reviews should be comprehensive yet focused, critically evaluating the existing literature while identifying unanswered questions and future directions. Visual materials that clarify complex hormonal pathways or clinical algorithms are strongly encouraged. All reviews undergo rigorous peer review to ensure accuracy, balance, and clinical relevance.

FREQUENTLY ASKED QUESTIONSFAQ About Nature Reviews Endocrinology

What is the Nature Reviews Endocrinology impact factor for 2025?

The 2025 impact factor is 39.1, as reported in the Clarivate JCR (June 2026).

Is Nature Reviews Endocrinology Q1 in Endocrinology?

Yes, Nature Reviews Endocrinology holds a Q1 ranking in the Endocrinology category.

Who publishes Nature Reviews Endocrinology?

Springer Nature has published Nature Reviews Endocrinology since its founding in 2005.

What is the CiteScore?

The Scopus CiteScore is 48.5.

Does Nature Reviews Endocrinology publish original research?

No, the journal publishes commissioned reviews, perspectives, and opinion articles in endocrinology and metabolism.

What is the ISSN?

The ISSN is 1759-5029.

What endocrine topics are covered?

Diabetes, thyroid, adrenal, pituitary, bone metabolism, reproductive endocrinology, neuroendocrinology, obesity, lipids, endocrine oncology, and hormone signaling.

How often is Nature Reviews Endocrinology published?

The journal is published monthly.

Similar Posts